发明授权
- 专利标题： Inhibitors of hepatitis C virus NS3 protease
- 专利标题（中）： 丙型肝炎病毒NS3蛋白酶抑制剂
-
申请号： US11645181申请日： 2006-12-21
-
公开(公告)号： US07423058B2公开(公告)日： 2008-09-09
- 发明人: Stephane L. Bogen , Weidong Pan , Sumei Ruan , Kevin X. Chen , Ashok Arasappan , Srikanth Venkatraman , Latha G. Nair , Mousumi Sannigrahi , Frank Bennett , Anil K. Saksena , F. George Njoroge , Viyyoor M. Girijavallabhan
- 申请人： Stephane L. Bogen , Weidong Pan , Sumei Ruan , Kevin X. Chen , Ashok Arasappan , Srikanth Venkatraman , Latha G. Nair , Mousumi Sannigrahi , Frank Bennett , Anil K. Saksena , F. George Njoroge , Viyyoor M. Girijavallabhan
- 申请人地址： US NJ Kenilworth
- 专利权人： Schering Corporation
- 当前专利权人： Schering Corporation
- 当前专利权人地址： US NJ Kenilworth
- 代理商 Palaiyur S. Kalyanaraman; Serena Farquharson-Torres
- 主分类号： A61K31/401
- IPC分类号： A61K31/401 ; C07D207/08
摘要：
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
公开/授权文献
- US20070142301A1 Novel inhibitors of Hepatitis C virus NS3 protease 公开/授权日：2007-06-21
信息查询
IPC分类:
